EFFICACY AND TOLERABILITY OF FOURTEEN-DAY SEQUENTIAL QUADRUPLE REGIMEN: PANTOPRAZOLE, BISMUTH, AMOXICILLIN, METRONIDAZOLE AND OR FURAZOLIDONE AS FIRST-LINE THERAPY FOR ERADICATION OF HELICOBACTER PYLORI: A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL.

MLA

Mansour-Ghanaei, Fariborz, et al. “Efficacy and Tolerability of Fourteen-Day Sequential Quadruple Regimen: Pantoprazole, Bismuth, Amoxicillin, Metronidazole and or Furazolidone as First-Line Therapy for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Clinical Trial.” EXCLI Journal, vol. 18, Jan. 2019, pp. 644–52. EBSCOhost, https://doi.org/10.17179/excli2019-1613.

APA

Mansour-Ghanaei, F., Samadi, A., Joukar, F., Fakheri, H. T., Hassanipour, S., Ashoobi, M. T., Soltanipour, S., Alizadeh, A., Rezamand, G., & Fathalipour, M. (2019). Efficacy and Tolerability of Fourteen-Day Sequential Quadruple Regimen: Pantoprazole, Bismuth, Amoxicillin, Metronidazole and or Furazolidone as First-Line Therapy for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Clinical Trial. EXCLI Journal, 18, 644–652. https://doi.org/10.17179/excli2019-1613

Chicago

Mansour-Ghanaei, Fariborz, Alireza Samadi, Farahnaz Joukar, Hafez Tirgar Fakheri, Soheil Hassanipour, Mohammad Taghi Ashoobi, Soheil Soltanipour, Ahmad Alizadeh, Gholamreza Rezamand, and Mohammad Fathalipour. 2019. “Efficacy and Tolerability of Fourteen-Day Sequential Quadruple Regimen: Pantoprazole, Bismuth, Amoxicillin, Metronidazole and or Furazolidone as First-Line Therapy for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Clinical Trial.” EXCLI Journal 18 (January): 644–52. doi:10.17179/excli2019-1613.